Advances in the Diagnosis, Treatment and Prognosis of Lymphangioleiomyomatosis

Lymphangioleiomyomatosis (LAM) is a rare, multisystemic, low-grade neoplasm character-ized by diffuse cystic lesions in the lung.In recent years, emerging imaging examination such as 68Ga-NEB PET-CT scan provides efficient and precise non-invasive diagnostic methods to detect lymphatic circulation a...

Full description

Bibliographic Details
Main Authors: CHENG Chongsheng, LIU Song, YANG Yanli, HOU Guozhu, CHENH Wuying, ZHANG Tengyue, HU Danjing, TIAN Xinlun, XU Kaifeng
Format: Article
Language:zho
Published: Editorial Office of Journal of Rare Diseases 2022-01-01
Series:罕见病研究
Subjects:
Online Access:https://jrd.chard.org.cn/article/doi/10.12376/j.issn.2097-0501.2022.01.007
_version_ 1797369835524456448
author CHENG Chongsheng
LIU Song
YANG Yanli
HOU Guozhu
CHENH Wuying
ZHANG Tengyue
HU Danjing
TIAN Xinlun
XU Kaifeng
author_facet CHENG Chongsheng
LIU Song
YANG Yanli
HOU Guozhu
CHENH Wuying
ZHANG Tengyue
HU Danjing
TIAN Xinlun
XU Kaifeng
author_sort CHENG Chongsheng
collection DOAJ
description Lymphangioleiomyomatosis (LAM) is a rare, multisystemic, low-grade neoplasm character-ized by diffuse cystic lesions in the lung.In recent years, emerging imaging examination such as 68Ga-NEB PET-CT scan provides efficient and precise non-invasive diagnostic methods to detect lymphatic circulation abnormalities in LAM patients. The long-term efficacy and safety of sirolimus for LAM has accumulated further evidence, and genetic profiling studies have unveiled more information of genetic mechanisms. Prognosis of LAM has been much improved. We briefly reviewed the research advances of LAM in China and other countires.
first_indexed 2024-03-08T17:52:38Z
format Article
id doaj.art-f020358105574bb0948269dfacaab995
institution Directory Open Access Journal
issn 2097-0501
language zho
last_indexed 2024-03-08T17:52:38Z
publishDate 2022-01-01
publisher Editorial Office of Journal of Rare Diseases
record_format Article
series 罕见病研究
spelling doaj.art-f020358105574bb0948269dfacaab9952024-01-02T07:19:31ZzhoEditorial Office of Journal of Rare Diseases罕见病研究2097-05012022-01-0111384410.12376/j.issn.2097-0501.2022.01.007Advances in the Diagnosis, Treatment and Prognosis of LymphangioleiomyomatosisCHENG ChongshengLIU SongYANG YanliHOU GuozhuCHENH WuyingZHANG TengyueHU DanjingTIAN XinlunXU KaifengLymphangioleiomyomatosis (LAM) is a rare, multisystemic, low-grade neoplasm character-ized by diffuse cystic lesions in the lung.In recent years, emerging imaging examination such as 68Ga-NEB PET-CT scan provides efficient and precise non-invasive diagnostic methods to detect lymphatic circulation abnormalities in LAM patients. The long-term efficacy and safety of sirolimus for LAM has accumulated further evidence, and genetic profiling studies have unveiled more information of genetic mechanisms. Prognosis of LAM has been much improved. We briefly reviewed the research advances of LAM in China and other countires.https://jrd.chard.org.cn/article/doi/10.12376/j.issn.2097-0501.2022.01.007lymphangioleiomyomatosisdiagnosistreatment
spellingShingle CHENG Chongsheng
LIU Song
YANG Yanli
HOU Guozhu
CHENH Wuying
ZHANG Tengyue
HU Danjing
TIAN Xinlun
XU Kaifeng
Advances in the Diagnosis, Treatment and Prognosis of Lymphangioleiomyomatosis
罕见病研究
lymphangioleiomyomatosis
diagnosis
treatment
title Advances in the Diagnosis, Treatment and Prognosis of Lymphangioleiomyomatosis
title_full Advances in the Diagnosis, Treatment and Prognosis of Lymphangioleiomyomatosis
title_fullStr Advances in the Diagnosis, Treatment and Prognosis of Lymphangioleiomyomatosis
title_full_unstemmed Advances in the Diagnosis, Treatment and Prognosis of Lymphangioleiomyomatosis
title_short Advances in the Diagnosis, Treatment and Prognosis of Lymphangioleiomyomatosis
title_sort advances in the diagnosis treatment and prognosis of lymphangioleiomyomatosis
topic lymphangioleiomyomatosis
diagnosis
treatment
url https://jrd.chard.org.cn/article/doi/10.12376/j.issn.2097-0501.2022.01.007
work_keys_str_mv AT chengchongsheng advancesinthediagnosistreatmentandprognosisoflymphangioleiomyomatosis
AT liusong advancesinthediagnosistreatmentandprognosisoflymphangioleiomyomatosis
AT yangyanli advancesinthediagnosistreatmentandprognosisoflymphangioleiomyomatosis
AT houguozhu advancesinthediagnosistreatmentandprognosisoflymphangioleiomyomatosis
AT chenhwuying advancesinthediagnosistreatmentandprognosisoflymphangioleiomyomatosis
AT zhangtengyue advancesinthediagnosistreatmentandprognosisoflymphangioleiomyomatosis
AT hudanjing advancesinthediagnosistreatmentandprognosisoflymphangioleiomyomatosis
AT tianxinlun advancesinthediagnosistreatmentandprognosisoflymphangioleiomyomatosis
AT xukaifeng advancesinthediagnosistreatmentandprognosisoflymphangioleiomyomatosis